1. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials;Calverley;Lancet,2009
2. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials;Fabbri;Lancet,2009
3. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor;Bundschuh;J Pharmacol Exp Ther,2001
4. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro;Hatzelmann;J Pharmacol Exp Ther,2001
5. The preclinical pharmacology of roflumilast-a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease;Hatzelmann;Pulm Pharmacol Ther